Search Results - "Gilewski, T A"

Effect of Adjuvant Tamoxifen on the Endometrium in Women With Breast Cancer: A Prospective Study Using Office Endometrial Biopsy by BARAKAT, R. R, GILEWSKI, T. A, ALMADRONES, L, SAIGO, P. E, VENKATRAMAN, E, HUDIS, C, HOSKINS, W. J

“…To determine the frequency of developing abnormal pathologic changes in the endometria of tamoxifen-treated women. To characterize the type of pathologic…”
Get full text

Paclitaxel as second and subsequent therapy for metastatic breast cancer: activity independent of prior anthracycline response by Seidman, A D, Reichman, B S, Crown, J P, Yao, T J, Currie, V, Hakes, T B, Hudis, C A, Gilewski, T A, Baselga, J, Forsythe, P

“…Two phase II clinical trials were performed to determine efficacy and tolerability of paclitaxel (Taxol; Bristol-Myers Squibb Co, Wallingford, CT) and…”
Get more information

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer by Seidman, A D, Hochhauser, D, Gollub, M, Edelman, B, Yao, T J, Hudis, C A, Francis, P, Fennelly, D, Gilewski, T A, Moynahan, M E, Currie, V, Baselga, J, Tong, W, O'Donaghue, M, Salvaggio, R, Auguste, L, Spriggs, D, Norton, L

“…A phase II trial of paclitaxel infused over 96 hours in patients with metastatic breast cancer with demonstrated disease progression (PD) during short-infusion…”
Get more information

Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancer by Hudis, C A, Seidman, A D, Crown, J P, Balmaceda, C, Freilich, R, Gilewski, T A, Hakes, T B, Currie, V, Lebwohl, D E, Baselga, J, Raptis, G, Gollub, M, Robles, M, Bruno, R, Norton, L

“…Because docetaxel (Taxotere, RP 56976; Rhone-Poulenc Rorer, Antony, France) appeared to be active against breast cancer in phase I trials, we performed this…”
Get more information

Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer by Reichman, B S, Seidman, A D, Crown, J P, Heelan, R, Hakes, T B, Lebwohl, D E, Gilewski, T A, Surbone, A, Currie, V, Hudis, C A

“…A phase II study of Taxol (paclitaxel; Bristol-Myers Squibb Co, Princeton, NJ) as initial chemotherapy for metastatic breast cancer was conducted. Recombinant…”
Get more information

An experimental analysis of classically conditioned nausea during cancer chemotherapy by Bovbjerg, D H, Redd, W H, Jacobsen, P B, Manne, S L, Taylor, K L, Surbone, A, Crown, J P, Norton, L, Gilewski, T A, Hudis, C A

“…This study investigated classical conditioning in women undergoing outpatient adjuvant chemotherapy for breast cancer. Breast cancer chemotherapy outpatients…”
Get more information

Preliminary experience with paclitaxel (Taxol) plus recombinant human granulocyte colony-stimulating factor in the treatment of breast cancer by Seidman, A D, Norton, L, Reichman, B S, Crown, J P, Yao, T J, Heelan, R, Hakes, T B, Lebwohl, D E, Gilewski, T A, Surbone, A

“…Single-agent paclitaxel (TAXOL) was administered to 79 patients with stage IV breast cancer. Twenty-eight patients had no prior chemotherapy (for metastatic…”
Get more information

Effective chemotherapy for melanoma after treatment with interleukin-2 by Richards, J M, Gilewski, T A, Ramming, K, Mitchel, B, Doane, L L, Vogelzang, N J

“…Twenty patients with biopsy-proven metastatic malignant melanoma, previously treated with interleukin-2 (IL-2), received combination chemotherapy for…”
Get more information

Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique by Vardiman, J W, Gilewski, T A, Ratain, M J, Bitter, M A, Bradlow, B A, Golomb, H M

“…The concomitant presence of B antigens and of the antigen recognized by the monoclonal antibody Leu-M5 (CD11c) on neoplastic lymphoid cells has been reported…”
Get more information

Conditioned Emotional Distress in Women Receiving Chemotherapy for Breast Cancer by Jacobsen, Paul B, Bovbjerg, Dana H, Schwartz, Marc D, Hudis, Clifford A, Gilewski, Teresa A, Norton, Larry

“…This study investigated whether women undergoing outpatient chemotherapy for breast cancer can develop classically conditioned emotional distress. Women…”
Get full text

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor. A randomized trial by Kritz, A, Crown, J P, Motzer, R J, Reich, L M, Heller, G, Moore, M P, Hamilton, N, Yao, T J, Heelan, R T, Schneider, J G

“…This study compared the efficacy of granulocyte-macrophage colony-stimulating factor (GM-CSF) alone or in combination with peripheral blood-derived…”
Get more information

Taxol plus recombinant human granulocyte-colony stimulating factor as initial and as salvage chemotherapy for metastatic breast cancer: a preliminary report by Seidman, A D, Reichman, B S, Crown, J P, Yao, T J, Heelan, R, Hakes, T B, Lebwohl, D E, Gilewski, T A, Surbone, A, Currie, V

“…Twenty-eight patients received Taxol as their first chemotherapy for stage IV breast cancer. An additional 51 patients with extensive prior exposure to other…”
Get more information

Biologic response modifiers in non-Hodgkin's lymphomas by Gilewski, T A, Richards, J M

Get more information

Association of interleukin-2 therapy with staphylococcal bacteremia by Richards, J M, Gilewski, T A, Vogelzang, N J

“…The authors prospectively monitored patients undergoing leukapheresis for peripheral stem cell harvesting (PSCH) or lymphokine activated killer (LAK) cell…”
Get more information

Design of combination biotherapy studies: future goals and challenges by Gilewski, T A, Golomb, H M

“…The recent large-scale production of biomodulators, also known as biologic response modifiers, made possible through recombinant DNA technology, offers the…”
Get more information

Taxol and recombinant human granulocyte colony-stimulating factor, an active regimen as initial therapy for metastatic breast cancer. A preliminary report by Reichman, B S, Seidman, A D, Crown, J P, Heelan, R, Yao, T J, Hakes, T B, Lebwohl, D E, Gilewski, T A, Surbone, A, Currie, V

Get more information

Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer by Seidman, A D, Norton, L, Reichman, B S, Crown, J P, Yao, T J, Hakes, T B, Lebwohl, D E, Gilewski, T A, Hudis, C A, Surbone, A

“…We treated 28 patients who had no prior chemotherapy for stage IV breast cancer and 51 patients with extensive prior exposure to other chemotherapeutic agents…”
Get more information

Abstract P2-16-12: An exploratory analysis of the role of dasatinib in preventing progression of disease in bone in patients with metastatic breast cancer by Cadoo, KA, Morris, PG, Lake, DE, D'Andrea, GM, Dickler, MN, Gilewski, TA, Dang, CT, McArthur, HL, Bromberg, JF, Goldfarb, SB, Modi, S, Robson, ME, Seidman, AD, Sklarin, NT, Norton, L, Hudis, CA, Fornier, MN

“…Abstract Introduction: The role of dasatinib, an oral SRC inhibitor is being explored for the treatment of metastatic breast cancer. In a phase I study, we…”
Get full text